2022
Transfusion support for the oncology patient
Stendahl K, Schulz W, Snyder E. Transfusion support for the oncology patient. 2022, 482-488. DOI: 10.1002/9781119719809.ch41.ChaptersOncology patientsTransfusion supportBlood productsRed blood cell transfusionAntibiotic-refractory infectionsAppropriate blood productsChronic transfusion supportMost oncology patientsSignificant transfusion reactionsBlood cell transfusionGranulocyte infusionsCell transfusionSevere neutropeniaOxygen-carrying capacityAppropriate therapyTransfusion therapyTransfusion reactionsPatientsABO antigensABO groupHost antibodiesTransfusion servicesRBC unitsBlood componentsWhole blood
2017
A novel network analysis tool to identify relationships between disease states and risks for red blood cell alloimmunization
Celli R, Schulz W, Hendrickson JE, Tormey CA. A novel network analysis tool to identify relationships between disease states and risks for red blood cell alloimmunization. Vox Sanguinis 2017, 112: 469-472. PMID: 28337751, DOI: 10.1111/vox.12515.Peer-Reviewed Original Research
2015
A Novel Network Analysis Tool to Identify Relationships Between Disease States and Risk for RBC Alloimmunization
Celli R, Schulz W, Hendrickson J, Tormey C. A Novel Network Analysis Tool to Identify Relationships Between Disease States and Risk for RBC Alloimmunization. Blood 2015, 126: 2349. DOI: 10.1182/blood.v126.23.2349.2349.Peer-Reviewed Original ResearchDisease statesControl cohortAcute myeloid leukemia/myelodysplastic syndromeLeukemia/myelodysplastic syndromeRed blood cell alloimmunizationChronic transfusion supportHyper-responder groupAcute renal failureAML/MDSAcute myocardial infarctionICD-9 codesDevelopment of alloantibodiesSpecific medical conditionsElectronic medical recordsSignificant disease associationCertain disease statesAlloimmunized individualsRBC alloimmunizationGastrointestinal bleedPulmonary hypertensionRenal failureTransfusion burdenTransfusion supportMale patientsRBC transfusion